The use of planned replacement contact lenses to redistribute the epitheliul amd so correct for ametropia is called orthokeratology (OK). The lens in effect flattens (or steepens) the cornea by a process that includes the redistribution of epithelial tissue. As this is an intervention resulting in a change to a target tissue does that not make OK a form of treatment? And if that is the case, where does the law stand regarding the provision of OK treatment by contact lens opticians? Just as with the use of P category medicines, should there be some clarification of this grey area? My view is that CLOs have the skill set to perfectly adequately be involved in both cases. I feel they should be able to practice in the knowledge that they do so within the legal framework.
Opinion